M. Peukert

579 total citations
20 papers, 410 citations indexed

About

M. Peukert is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Peukert has authored 20 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Peukert's work include Influenza Virus Research Studies (3 papers), Melanoma and MAPK Pathways (3 papers) and Beetle Biology and Toxicology Studies (2 papers). M. Peukert is often cited by papers focused on Influenza Virus Research Studies (3 papers), Melanoma and MAPK Pathways (3 papers) and Beetle Biology and Toxicology Studies (2 papers). M. Peukert collaborates with scholars based in Germany, Netherlands and Bulgaria. M. Peukert's co-authors include H. Sindermann, H. Riethmüller-Winzen, H. Eibl, Clemens Unger, Peter Hilgard, J. R. Kalden, Gerhard Jahn, B Fleckenstein, Thomas Harrer and Andreas S. Baur and has published in prestigious journals such as Annals of Oncology, Human Reproduction and Urology.

In The Last Decade

M. Peukert

20 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Peukert Germany 9 142 137 89 84 72 20 410
Cristiana Godeas Italy 10 142 1.0× 19 0.1× 54 0.6× 18 0.2× 87 1.2× 13 443
Won G. Ng United States 20 218 1.5× 180 1.3× 56 0.6× 6 0.1× 57 0.8× 42 805
W.G. Ng United States 10 119 0.8× 98 0.7× 36 0.4× 5 0.1× 76 1.1× 27 442
W Scheef Germany 10 102 0.7× 11 0.1× 53 0.6× 20 0.2× 21 0.3× 23 410
Schwartz Mk United States 10 162 1.1× 16 0.1× 140 1.6× 9 0.1× 8 0.1× 23 414
Borroughs R. Hill United States 10 244 1.7× 28 0.2× 21 0.2× 13 0.2× 10 0.1× 12 489
Yasunori Nishio Japan 10 117 0.8× 27 0.2× 12 0.1× 9 0.1× 12 0.2× 41 464
Qinyang Xu China 12 248 1.7× 12 0.1× 38 0.4× 7 0.1× 40 0.6× 19 398
Riccardo Cianti Italy 8 135 1.0× 8 0.1× 79 0.9× 8 0.1× 55 0.8× 10 410
Aleix Navarro‐Sastre Spain 17 331 2.3× 93 0.7× 84 0.9× 22 0.3× 2 0.0× 21 624

Countries citing papers authored by M. Peukert

Since Specialization
Citations

This map shows the geographic impact of M. Peukert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Peukert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Peukert more than expected).

Fields of papers citing papers by M. Peukert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Peukert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Peukert. The network helps show where M. Peukert may publish in the future.

Co-authorship network of co-authors of M. Peukert

This figure shows the co-authorship network connecting the top 25 collaborators of M. Peukert. A scholar is included among the top collaborators of M. Peukert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Peukert. M. Peukert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Unger, Christian, H. Sindermann, M. Peukert, et al.. (2015). Hexadecylphosphocholine in the Topical Treatment of Skin Metastases in Breast Cancer Patients. Progress in tumor research. 34. 153–159. 6 indexed citations
2.
Debruyne, F.M.J., et al.. (2006). PD-02.11. Urology. 68. 8–9. 2 indexed citations
3.
Ubaldi, F., Carola Albano, M. Peukert, et al.. (1996). Endocrinology: Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in intracytoplasmic sperm injection cycles. Human Reproduction. 11(7). 1405–1407. 73 indexed citations
4.
Hermann, Róbert, G Niebch, Harald O. Borbe, et al.. (1996). Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers. European Journal of Pharmaceutical Sciences. 4(3). 167–174. 93 indexed citations
5.
Manegold, C., et al.. (1992). Oral ifosfamide-mesna: A clinical investigation in advanced non-small-cell lung cancer. Annals of Oncology. 3(9). 723–726. 10 indexed citations
6.
Peukert, M., et al.. (1991). Locoregional versus Systemic Chemotherapy in Metastatic Colorectal Cancer – Efficacy of an Additive Immunotherapy with Rubratin. Oncology Research and Treatment. 14(5). 406–410. 3 indexed citations
7.
Danhauser-Riedl, S., U. Bruntsch, M. Peukert, et al.. (1991). Phase I Study of Weekly Oral Miltefosine (Hexadecyl-Phosphocholine) in Cancer Patients. Oncology Research and Treatment. 14(5). 392–400. 14 indexed citations
8.
Baur, Andreas S., Thomas Harrer, M. Peukert, et al.. (1991). Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication. Journal of Molecular Medicine. 69(15). 722–724. 63 indexed citations
9.
Unger, Clemens, M. Peukert, H. Sindermann, et al.. (1990). Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients. Cancer Treatment Reviews. 17(2-3). 243–246. 50 indexed citations
10.
Sindermann, H., M. Peukert, & P. Hilgard. (1989). Bone marrow purging with mafosfamide ? A critical survey. Annals of Hematology. 59(5). 432–441. 11 indexed citations
11.
Gurtoo, Hira L., et al.. (1988). Basis and New Developments in the Field of Oxazaphosphorines. Cancer Investigation. 6(5). 513–532. 20 indexed citations
12.
Unger, Clemens, H. Eibl, H. W. von Heyden, et al.. (1988). Hexadecylphosphocholine (D 18506) in the Topical Treatment of Skin Metastases: A Phase-I Trial. Oncology Research and Treatment. 11(6). 295–296. 47 indexed citations
13.
Henß, H., et al.. (1987). Phase II trial of anaxirone in advanced non-small cell lung cancer.. PubMed. 71(5). 539–40. 2 indexed citations
14.
Wagner, Helmut, et al.. (1987). Phase II trial of 1,2,4-triglycidylurazol in patients with metastasized renal cell carcinoma.. PubMed. 71(2). 209–10. 1 indexed citations
15.
Queißer, W., et al.. (1986). Phase II studies of 1,2,4-triglycidyluracol (TGU) in solid tumors. Journal of Cancer Research and Clinical Oncology. 111(S1). S9–S9. 1 indexed citations
16.
Fiebig, H.H., W Wellens, M. Peukert, et al.. (1984). Phase-II-Studie des wasserlöslichen Nitrosoharnstoffes ACNU bei fortgeschrittenen kolorektalen Karzinomen. Oncology Research and Treatment. 7(6). 370–377. 3 indexed citations
17.
Peukert, M., et al.. (1983). [Incidence of liver cirrhosis in autopsy cases. A statistical autopsy study].. PubMed. 127(1-2). 33–8. 1 indexed citations
18.
Peukert, M., et al.. (1982). Comparison of the antigenicity and tolerance of an influenza aluminium oxide adsorbate vaccine with an aqueous vaccine.. PubMed. 3(3). 195–200. 3 indexed citations
19.
Peukert, M., et al.. (1982). Antibody formation after vaccination with adsorbed and non-adsorbed A/New Jersey/8/76 influenza vaccines.. PubMed. 3(3). 201–8. 1 indexed citations
20.
Ehrengut, W, et al.. (1980). Serologic response to whole, split and subunit influenza vaccines of persons with and without immunological experience towards influenza A/U.S.S.R.90/77 virus. Comparative Immunology Microbiology and Infectious Diseases. 3(1-2). 225–236. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristiana Godeas Breakdown of academic impact, for papers by Won G. Ng Breakdown of academic impact, for papers by W.G. Ng Breakdown of academic impact, for papers by W Scheef Breakdown of academic impact, for papers by Schwartz Mk Breakdown of academic impact, for papers by Borroughs R. Hill Breakdown of academic impact, for papers by Yasunori Nishio Breakdown of academic impact, for papers by Qinyang Xu Breakdown of academic impact, for papers by Riccardo Cianti Breakdown of academic impact, for papers by Aleix Navarro‐Sastre
Rankless by CCL
2026